search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Treatment after six ovulatory cycles with clomiphene


- candidate number3994
- NTR NumberNTR1449
- ISRCTNISRCTN wordt niet meer aangevraagd
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR16-sep-2008
- Secondary IDsP08-037 METC
- Public TitleTreatment after six ovulatory cycles with clomiphene
- Scientific TitleTREATMENT ALTERNATIVES FOR SUBFERTILE WOMEN WITH CLASS II ANOVULATION NOT CONCEIVING AFTER SIX OVULATORY CYCLES WITH CLOMIPHENE CITRATE
- ACRONYMN/A
- hypothesisGonadotropins after 5-7 ovulatory cycles with CC will lead to more multiple gestations and higher costs compared with extended CC treatment.
Combination of CC or gonadotropins with IUI may result in a higher pregnancy rate.
- Healt Condition(s) or Problem(s) studiedSubfertility, Ovulation, Clomiphene
- Inclusion criteria1. Patients with five to seven ovulatory cycles after CC treatment and no conception. Ovulation is assessed by a midluteal progesterone (> 16 nmol/l), basal temperature curve, detection of LH surge or history.
2. All patients have normal serum FSH (<10 IU/l), E2 (> 80 pmol/l), prolactin (0,05 0,80 IU/l) and thyroid-stimulating hormone (0,4 - 4,0 mU/l).
3. All women have patent Fallopian tubes, proven by hysterosalpingography (HSG), a negative Chlamydia antibody titre (CAT) or diagnostic laparoscopy combined with tubal testing (DLS and TT).
4. The partners have normal semen parameters according to the modified criteria of the World Health Organization (1999).
5. Age between 18 and 40 years.
- Exclusion criteria1. Patients who have previously been treated with gonadotropins or IVF are excluded.
2. Patients are excluded if they have intolerable symptoms when treated with CC like hot flashes affecting daily function, headaches, vision changes, and depression.
3. Patients are excluded if they are remaining anovulatory on CC 150 mg.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2008
- planned closingdate
- Target number of participants660
- InterventionsTo study the effectiveness of the following interventions in patients who have not conceived after 5 to 7 ovulatory cycles with CC treatment
1. Extended CC treatment
2. Extended CC treatment combined with IUI
3. Gonadotropins
4. Gonadotropins combined with IUI.
- Primary outcomeThe primary outcome will be pregnancies leading to live birth.
- Secondary outcomeSecondary outcomes will be:
- clinical pregnancy
- miscarriage
- multiple pregnancy
- occurrence of ovulation.
- TimepointsPreganacy or end of the study after 6 months.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIES Marleen J Nahuis
- CONTACT for SCIENTIFIC QUERIES Marleen J Nahuis
- Sponsor/Initiator Medisch Spectrum Twente
- Funding
(Source(s) of Monetary or Material Support)
Medisch Spectrum Twente, Enschede
- Publications
- Brief summaryOvulation induction with Clomiphene citrate (CC) is the first line treatment in subfertile women with WHO class II anovulation. Whereas almost 80% of these patients ovulate after CC, only 40 to 50% conceive. When unsuccessful in conception, treatment can be proceeded with gonadotropins. CC treatment is associated with a 8% risk of multiple gestation, whereas treatment with gonadotropins is associated with a risk of 30-40 %. At present, it is unclear for how many cycles ovulation induction with CC should be repeated. Alternatives are a switch to ovulation induction with gonadotropins and/or addition of intra-uterine insemination.
- Main changes (audit trail)Secondary outcome:
NEW
- Ongoing pregnancy
- RECORD16-sep-2008 - 5-jul-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl